![]()

In this newsletter, you'll see a story every week or two about some medical device manufacturer who's caught providing kickbacks or bribes for doctors who use its product. When they're caught, the device maker makes its mea culpas, pay its fines and goes right back to business--where, if history is any indication, they go right back to finding new ways to buy business.
The question is, what can regulators do to take the potential for corruption out of this system? Obviously, device and drug-makers are always going to have close relationships with physicians, so the incentive is always there, but perhaps it's possible to raise the risk or lower the reward.
Maybe it's time to try one or more of the following:
I'm not a device manufacturing business expert, nor am I an attorney, so I may be way off base here. What do you think regulators, professional associations or other stakeholders can take to lower the corruption level in medical device marketing? I'd love to hear your ideas [1]. -Anne [1]
Links:
[1] mailto:anne@fiercemarkets.com